SMI
11.787,82
PKT
+86,10
PKT
+0,74
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.07.12 | UBS overweight | HSBC | |
| 30.07.12 | Holcim buy | UBS AG | |
| 30.07.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 30.07.12 | ABB (Asea Brown Boveri) neutral | Exane-BNP Paribas SA | |
| 30.07.12 | Novartis hold | Vontobel Research | |
| 27.07.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 27.07.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
| 27.07.12 | Logitech neutral | UBS AG | |
| 27.07.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 27.07.12 | Logitech hold | Vontobel Research | |
| 26.07.12 | UBS hold | ING | |
| 26.07.12 | Sika neutral | Sarasin Research | |
| 26.07.12 | Logitech neutral | Sarasin Research | |
| 26.07.12 | ABB (Asea Brown Boveri) hold | ING | |
| 26.07.12 | Lonza neutral | UBS AG | |
| 26.07.12 | Lonza hold | Vontobel Research | |
| 26.07.12 | Logitech hold | Vontobel Research | |
| 26.07.12 | Sika hold | Vontobel Research | |
| 26.07.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 25.07.12 | UBS outperform | Exane-BNP Paribas SA | |
| 25.07.12 | Lonza neutral | Sarasin Research | |
| 25.07.12 | UBS neutral | Nomura | |
| 25.07.12 | Novartis buy | Nomura | |
| 25.07.12 | Novartis kaufen | Sarasin Research | |
| 25.07.12 | Swiss Re buy | Vontobel Research | |
| 25.07.12 | Lonza hold | Vontobel Research | |
| 25.07.12 | Holcim hold | Vontobel Research | |
| 24.07.12 | UBS neutral | Sarasin Research | |
| 24.07.12 | UBS hold | Commerzbank Corp. & Markets | |
| 24.07.12 | Swiss Re neutral | Nomura | |
| 24.07.12 | Swiss Life buy | Nomura | |
| 23.07.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 23.07.12 | UBS neutral | UBS AG | |
| 23.07.12 | Novartis hold | Vontobel Research | |
| 23.07.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.07.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 20.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 19.07.12 | Swisscom buy | Banc of America Securities-Merrill Lynch |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.